Wright Medical Group N.V

Wright Medical — Merger or Acquisition (December 2014)

36 slides from Wright Medical's merger presentation, Dec 2, 2014

  1. Slide 1: The Path to Extraordinary: Transformation and Creating Value Using the High Performance Management System

    Columbia School of Business – Investing in Medical Technologies Lecture The Path to Extraordinary: Transformation and Creating Value Using the High Performance Management System Bob Palmisano, President & CEO December 1, 2014

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statements

    Cautionary Note Regarding Forward-Looking Statements This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “pro

  3. Slide 3: Note on Non-GAAP Financial Measures

    Note on Non-GAAP Financial Measures Wright and Tornier use non-GAAP financial measures, including EBITDA, as adjusted. Their respective management teams believe that the presentation of these measures provides useful information to investors and that these measures may assist investors in evaluating

  4. Slide 4: Important Additional Information and Where To Find It

    Important Additional Information and Where To Find It In connection with the proposed merger, Tornier plans to file with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 that will include a joint proxy statement of Wright and Tornier that also constitutes a pros

  5. Slide 5: How I got here

    How I got here $2.6B $972M $744M $808M 4

  6. Slide 6: Focus and simplicity (Steve Jobs quote)

    That’s been one of my mantras — focus and simplicity. Simple can be harder than complex; you have to work hard to get your thinking clean to make it simple.” Steve Jobs 5

  7. Slide 7: Our company at a Glance

    Our company at a Glance Market Cap ~$1.5B NASDAQ: WMGI Extremities-Biologics company with leadership position in Lower Extremities — foot & ankle HQ Memphis, TN 2013 revenue: $242M products in 60 countries 1000 global employees 6

  8. Slide 8: Our products at a Glance

    Our products at a Glance Foot & Ankle Growth (Global Constant Currency Sales) 28% 23% INBONE® and INFINITY® 15% Total Ankle Systems 9% ORTHOLOC® Reconstructive Plates 2011 2012 2013 2014 YTD PRO-TOE® Hammertoe Implants 3% 10% Other 25% Upper Extremities Biologics Biologics 62% Foot & Ankle 2013 Sale

  9. Slide 9: Growth had stalled in Extremities

    Extended Deferred Prosecution Agreement (DPA) Growth had stalled in Extremities In the past… Low margin Outlook was grim and Cash intensive a break from status Mix 40% Extremities-Bio, 60% Ortho-Recon quo was needed 2010 2011 2012 2013 2014 Status Quo Sales Status Quo EPS 8

  10. Slide 10: Wright Medical: A Company Transformation

    Wright Medical: A Company Transformation 2011 2014 Singular Focus Multiple Lines Industry Leader Unclear Strategy High Growth Revenue Decline OrthoRecon R&D International Divestiture Acceleration Expansion Direct F&A MedEd M&A Sales Force Acceleration(5 Acquisitions) TRANSFORMATION 9

  11. Slide 11: Our Differentiated Business Model

    Our Differentiated Business Model Unique pure play company Focused on most attractive segments Leveraging strong competitive advantages Delivering industry-leading growth It sounds simple. But it takes clear differentiators and a determined execution 10

  12. Slide 12: Unique Pure Play Company

    1 Unique Pure Play Company Broad Product range Other companies Narrow Diversified Single-focus Focus on Extremities-Biologics 11

  13. Slide 13: Focused on Most Attractive, Higher Growth Segments of the Orthopedics Market

    2 Focused on Most Attractive, Higher Growth Segments of the Orthopedics Market Foot & Ankle Market Wright Medical focus U.S. = $1.1B 2011-2016 CAGR More concentrated call point Complex treatment issues, less mature products need innovative solutions significant mix opportunity Strong growth drivers

  14. Slide 14: Leveraging Strong Competitive Advantages

    3 Leveraging Strong Competitive Advantages Broad foot & ankle product portfolio – the “go to” one stop shop for doctors Strong R&D pipeline – to drive technology adoption Powerful competitive advantages “Sticky” relationships with surgeons – trained ~2,500 surgeons 2013 vs. 600 in 2011 Largest speci

  15. Slide 15: Delivering Industry-Leading Growth

    R ESU L T Delivering Industry-Leading Growth Wright 28%(2) Medical growing market growing faster 8-10%(1) fast… Foot & Ankle Wright Medical: Outgrowing a growth market Note 1: Millennium Research Group, Management Estimates Note 2: YTD (September 30, 2014) global constant currency foot & ankle reven

  16. Slide 16: Key initiatives on our pathway to success

    5 Targeted M&A 4 ors Expand internationally Best-in-class 3 medical education 2 Launch new products Extremities market Key initiatives on our 1 Increase U.S. sales growing in 8-10% range pathway to success force productivity 15

  17. Slide 17: FDA Approvable Letter for Augment Bone Graft

    On October 27, Wright Announced Receipt of FDA Approvable Letter for Augment® Bone Graft First clinically proven cost-effective alternative to autograft for ankle and/or hindfoot fusion — roughly a $300M U.S. market opportunity Final approval subject to customary preapproval inspections Assuming sat

  18. Slide 18: Our next chapter

    Our next chapter 17

  19. Slide 19: Wright and Tornier Agree to Merge

    October 27, 2014 Wright and Tornier Agree to Merge Creating Premier Global High-Growth Extremities-Biologics Company Combination Will Offer Comprehensive Upper and Lower Extremity Product Portfolio and Broad Global Reach Further Accelerates Growth Opportunities in Three of the Fastest Growing Areas

  20. Slide 20: Wright: A Company Transformation

    Wright: A Company Transformation Once integrated 2011 with Tornier, we anticipate: Lower Three Growth Platforms Multiple Lines Extremities Clear Strategy Unclear Strategy Biologics Revenue growth: Mid-teens Revenue growth: Low single digits Adj. EBITDA margins: approaching 20% in 3-4 years Market ca

  21. Slide 21: High Performance Management System (HPMS)

    Disciplined, data-driven management system and process High Performance Management System (HPMS) 20

  22. Slide 22: The essence of HPMS

    The essence of HPMS delighted BUSINESS customers SUCCESS satisfied shareholders motivated F employees I N BUSINESS SUCCESS A N C I Ensures that the “Vital Few” (versus A L the “Useful Many”) get done well 21

  23. Slide 23: A High Performance System

    A High Performance System A STEP-BY-STEP Customer approach to allocating Vision Voice resources, solving problems, making decisions, and Values Employee capturing opportunities Voice Mission Shareholder Voice 22

  24. Slide 24: Time is limited

    Time is limited Fill the box with the larger vital projects that GET RESULTS 23

  25. Slide 25: The 8-Step Breakthrough Process

    The 8-Step Breakthrough Process™ STEP ANOTHER Select DOING THE RIGHT 1 “Vital Few” Monitor and STEP 8 THINGS RIGHT Recycle if Necessary Execute With STEP 7 Excellence Develop a Transition Plan STEP 6 Define The Desired STEP 5 State & Needed Determine The Processes The Current State STEP 4 & Processe

  26. Slide 26: How does HPMS work?

    How does HPMS work? BREAKTHROUGH TICKET(S) SUCCESS TREE To Do The Right Things Right… Guiding Prescriptive ? Values Vision The STI Desired BreakThrough State Directive Process™ Current 5 Mission Customer VITAL - Step 3 State 4 6 Transition Plan Teams 7 Employee FEW What? Quality Step 2 Who? Implemen

  27. Slide 27: Corporate Success Tree

    Corporate Success Tree Shared Values Vision The Specialty Orthopaedic Company People Love Passion • Accountability Quality Policy We will meet or exceed the expectations of our customers by complying with Customer Focus requirements, by maintaining the effectiveness of our quality management system,

  28. Slide 28: Typical Current State

    Typical Current State A A B A B B A B A B 27

  29. Slide 29: The Desired State

    The Desired State If we’re all supposed to pull in the same direction, “it would help if we knew where we are going.—R. Palermo A B 28

  30. Slide 30: Lessons learned along the way

    Lessons learned along the way A B 29

  31. Slide 31: Vital Few must be driven by what is transformational

    Vital Few—must be driven by what is transformational for Customers, Employees and Shareholders The Current State The Desired State Focused Focused Communication tough lessons along the way 30

  32. Slide 32: If it's ugly, call it ugly

    If it’s ugly, call it ugly… No sugar coating Reward Recognition Training Coaching Key Measures The Current State The Desired State Role Model Leaders Focused Focused Strategies Communications tough lessons along the way 31

  33. Slide 33: All elements of plan must be addressed

    All elements of plan must be addressed Reward Recognition Training Coaching Key Measures The Current State The Desired State Focused Focused Strategies Role Model Leaders Communications tough lessons along the way 32

  34. Slide 34: Alignment to desired state is critical

    Alignment to desired state is critical Reward Recognition Training Coaching Key Measures The Current State The Desired State Focused Focused Strategies Role Model Leaders Communications tough lessons along the way 33

  35. Slide 35: Focused Excellence will propel Wright

    Focused Excellence will propel Wright to be the Premier Global High-Growth Extremities-Biologics Company Focused on being a great company! Growth & profitability Build a driven culture of excellence 34

  36. Slide 36: A good plan violently executed now

    A good plan violently executed now is better than a perfect plan executed next week. -General George S. Patton It takes time The journey is littered with obstacles Stay true to the system Celebrate the small victories Invest in it to gain momentum Perfection is your enemy 35 Note on Non-GAAP Financi

Wright Medical Group — Merger or Acquisition (December 2014) on 6ix